Showing results (1-10 of 233) with videos related to
Sort By:
Pageof 24
International Journal of Clinical Practice|June 13, 2003
COX-LOX inhibition: current evidence for an emerging new therapyM M Skelly, C J HawkeyCurrent Pharmaceutical Design|October 8, 2003
Dual COX inhibition and upper gastrointestinal damageM M Skelly, C J HawkeyCurrent Pharmaceutical Design|April 12, 2002
Gastrointestinal safety of selective COX-2 inhibitorsC J Hawkey, M M SkellyBritish Journal of Clinical Pharmacology|May 26, 2006
Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugsC J Hawkey, G M Hawkey, S Everitt, et al.Bailliere'S Best Practice & Research. Clinical Gastroenterology|April 5, 2000
Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugsC J HawkeyEuropean Journal of Gastroenterology & Hepatology|August 10, 2000
What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?C J HawkeyScandinavian Journal of Gastroenterology. Supplement|January 1, 1993
Gastroduodenal problems associated with non-steroidal, anti-inflammatory drugs (NSAIDs)C J HawkeyAlimentary Pharmacology & Therapeutics|September 1, 2004
Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?C J HawkeyAlimentary Pharmacology & Therapeutics|December 1, 1987
Review: acute human models of gastric mucosal injuryC J HawkeyMethods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
Prostaglandins: mucosal protection and peptic ulcerationC J HawkeyPageof 24